Toshinori Hinoue, Ph.D.
Affiliations: | 2009 | Biochemistry and Molecular Biology | University of Southern California, Los Angeles, CA, United States |
Area:
Molecular Biology, GeneticsGoogle:
"Toshinori Hinoue"Parents
Sign in to add mentor| Peter W. Laird | grad student | 2009 | USC | |
| (DNA hypermethylation: Its role in colorectal tumorigenesis and potential clinical applications.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ellrott K, Wong CK, Yau C, et al. (2024) Classification of non-TCGA cancer samples to TCGA molecular subtypes using compact feature sets. Cancer Cell |
| Sundaram L, Kumar A, Zatzman M, et al. (2024) Single-cell chromatin accessibility reveals malignant regulatory programs in primary human cancers. Science (New York, N.Y.). 385: eadk9217 |
| Kaur D, Lee SM, Goldberg D, et al. (2023) Comprehensive Evaluation of The Infinium Human MethylationEPIC v2 BeadChip. Epigenetics Communications. 3 |
| Miller AL, Perurena N, Gardner A, et al. (2023) DAB2IP is a bifunctional tumor suppressor that regulates wildtype RAS and inflammatory cascades in KRAS mutant colon cancer. Cancer Research |
| Garcia-Recio S, Hinoue T, Wheeler GL, et al. (2022) Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis. Nature Cancer |
| Zhou W, Hinoue T, Barnes B, et al. (2022) DNA methylation dynamics and dysregulation delineated by high-throughput profiling in the mouse. Cell Genomics. 2 |
| Carrot-Zhang J, Yao X, Devarakonda S, et al. (2021) Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway. Cell Reports. 34: 108784 |
| Carrot-Zhang J, Yao X, Devarakonda S, et al. (2021) Whole-genome characterization of lung adenocarcinomas lacking the RTK/RAS/RAF pathway. Cell Reports. 34: 108707 |
| Wheeler DA, Takebe N, Hinoue T, et al. (2020) Molecular Features of Cancers Exhibiting Exceptional Responses to Treatment. Cancer Cell |
| Coyne GO, Kummar S, Meehan RS, et al. (2020) Phase I trial of TRC102 (methoxyamine HCl) in combination with temozolomide in patients with relapsed solid tumors and lymphomas. Oncotarget. 11: 3959-3971 |